CSF2 and neoplasm: Novel approaches include ice microneedle arrays for delivering living tumor cell vaccines with sustained granulocyte-macrophage colony-stimulating factor secretion [183] and photothermal ultra-swelling microneedle patches achieving remarkable swelling ratios exceeding 2000% for efficient tumor antigen delivery [184].